Cargando…

Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism

Pharmacological studies implicate the blockade of adenosine receptorsas an effective strategy for reducing Parkinson’s disease (PD) symptoms. The objective of this study is to elucidate the possible protective effects of ZM241385 and 8-cyclopentyl-1, 3-dipropylxanthine, two selective A(2A) and A(1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fathalla, Ahmed M., Soliman, Amira M., Ali, Mohamed H., Moustafa, Ahmed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770055/ https://www.ncbi.nlm.nih.gov/pubmed/26973484 http://dx.doi.org/10.3389/fnbeh.2016.00035

Ejemplares similares

Commentary: Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: de Souza, Marina F., et al.
Publicado: (2017)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
por: Rodrigues, Lais S., et al.
Publicado: (2014)

Levodopa Enhances Reward Learning but Impairs Reversal Learning in Parkinson's Disease Patients
por: Moustafa, Ahmed A.
Publicado: (2011)

Overexpression of Mitochondrial Ligases Reverses Rotenone-Induced Effects in a Drosophila Model of Parkinson’s Disease
por: Doktór, Bartosz, et al.
Publicado: (2019)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
por: Ramalingam, Mahesh, et al.
Publicado: (2019)

The role of frontostriatal impairment in freezing of gait in Parkinson's disease
por: Shine, James M., et al.
Publicado: (2013)

Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease
por: Yang, Xiaodong, et al.
Publicado: (2018)

Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease
por: Wise, John P., et al.
Publicado: (2018)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson’s Disease
por: Shalash, Ali Soliman, et al.
Publicado: (2017)

Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson's disease in rotenone-treated rats
por: Monir, Dina M., et al.
Publicado: (2020)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

Valeriana officinalis Counteracts Rotenone Effects on Spreading Depression in the Rat Brain in vivo and Protects Against Rotenone Cytotoxicity Toward Rat Glioma C6 Cells in vitro
por: Amaral de Brito, Ana Paula, et al.
Publicado: (2020)

On the relationship among different motor processes: a computational modeling approach
por: Moustafa, Ahmed A.
Publicado: (2015)

Motor and cognitive changes in normal aging
por: Moustafa, Ahmed A.
Publicado: (2014)

Electroacupuncture Pretreatment Prevents Cognitive Impairment Induced by Cerebral Ischemia–Reperfusion via Adenosine A1 Receptors in Rats
por: Shi, Yiyi, et al.
Publicado: (2021)

Adenosine A(2A) receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function
por: Oliveros, Alfredo, et al.
Publicado: (2022)

Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
por: Zhang, Dongdong, et al.
Publicado: (2021)

Freezing of gait and response conflict in Parkinson's disease: computational directions
por: Moustafa, Ahmed A.
Publicado: (2014)

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats
por: Ahmed, Sanaa, et al.
Publicado: (2022)

Neural and behavioral substrates of subtypes of Parkinson’s disease
por: Moustafa, Ahmed A., et al.
Publicado: (2013)

Impaired Fine Motor Function of the Asymptomatic Hand in Unilateral Parkinson’s Disease
por: Dan, Xiaojuan, et al.
Publicado: (2019)

Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease
por: Abhangi, Kinjal V, et al.
Publicado: (2022)

A commentary on: “A 12-year population-based study of freezing of gait in Parkinson's disease”
por: Crouse, Jacob J., et al.
Publicado: (2015)

The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson’s Disease
por: Thomas Broome, Sarah, et al.
Publicado: (2022)

A commentary on “Antipsychotic-induced Parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders”
por: Salem, Amir, et al.
Publicado: (2015)

Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models
por: Ayajuddin, Mohamad, et al.
Publicado: (2022)

Ndfip1 Prevents Rotenone-Induced Neurotoxicity and Upregulation of α-Synuclein in SH-SY5Y Cells
por: Liu, Xin, et al.
Publicado: (2021)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Evidence of Oropharyngeal Dysfunction in Feeding in the Rat Rotenone Model of Parkinson's Disease
por: Gould, François D. H., et al.
Publicado: (2018)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Parkinson’s Disease Progression: Implicit Acquisition, Cognitive and Motor Impairments, and Medication Effects
por: Pavão, Rodrigo, et al.
Publicado: (2012)

Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
por: Tibar, Houyam, et al.
Publicado: (2018)

Quantifying upper limb motor impairment in people with Parkinson’s disease: a physiological profiling approach
por: Ingram, Lewis A., et al.
Publicado: (2021)

Huangqin Decoction Exerts Beneficial Effects on Rotenone-Induced Rat Model of Parkinson's Disease by Improving Mitochondrial Dysfunction and Alleviating Metabolic Abnormality of Mitochondria
por: Gao, Li, et al.
Publicado: (2022)

Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A
por: Yu, Lijia, et al.
Publicado: (2017)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cqqc4ruo2qo62i72m3u8ldrjn1